| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics, Molecular Targets, and Chemical Biology |
Division of Clinical Pharmacology, Departments of Pharmacology and Experimental Therapeutics and Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania
Requests for reprints: Giovanni Mario Pitari, Division of Clinical Pharmacology, Thomas Jefferson University, 1100 Walnut Street MOB 811, Philadelphia, PA 19107. Phone: 215-955-5647; Fax: 215-955-7006; E-mail: gmpitari{at}yahoo.com.
Bacterial diarrheagenic heat-stable enterotoxins induce colon cancer cell cytostasis by targeting guanylyl cyclase C (GCC) signaling. Anticancer actions of these toxins are mediated by cyclic guanosine 3',5'-monophosphate (cGMP)dependent influx of Ca2+ through cyclic nucleotide-gated channels. However, prolonged stimulation of GCC produces resistance in tumor cells to heat-stable enterotoxininduced cytostasis. Resistance reflects rapid (tachyphylaxis) and slow (bradyphylaxis) mechanisms of desensitization induced by cGMP. Tachyphylaxis is mediated by cGMP-dependent protein kinase, which limits the conductance of cyclic nucleotide-gated channels, reducing the influx of Ca2+ propagating the antiproliferative signal from the membrane to the nucleus. In contrast, bradyphylaxis is mediated by cGMP-dependent allosteric activation of phosphodiesterase 5, which shapes the amplitude and duration of heat-stable enterotoxindependent cyclic nucleotide accumulation required for cytostasis. Importantly, interruption of tachyphylaxis and bradyphylaxis restores cancer cell cytostasis induced by heat-stable enterotoxins. Thus, regimens that incorporate cytostatic bacterial enterotoxins and inhibitors of cGMP-mediated desensitization offer a previously unrecognized therapeutic paradigm for treatment and prevention of colorectal cancer.
This article has been cited by other articles:
![]() |
N. Basu, R. Bhandari, V. T. Natarajan, and S. S. Visweswariah Cross Talk between Receptor Guanylyl Cyclase C and c-src Tyrosine Kinase Regulates Colon Cancer Cell Cytostasis Mol. Cell. Biol., October 1, 2009; 29(19): 5277 - 5289. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. LIU, D. OVERBEY, L. D. WATKINSON, S. DAIBES-FIGUEROA, T. J. HOFFMAN, L. R. FORTE, W. A. VOLKERT, and M. F. GIBLIN In Vivo Imaging of Human Colorectal Cancer Using Radiolabeled Analogs of the Uroguanylin Peptide Hormone Anticancer Res, October 1, 2009; 29(10): 3777 - 3783. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Pitari, J. E. Lin, F. J. Shah, W. J. Lubbe, D. S. Zuzga, P. Li, S. Schulz, and S. A. Waldman Enterotoxin preconditioning restores calcium-sensing receptor-mediated cytostasis in colon cancer cells Carcinogenesis, August 1, 2008; 29(8): 1601 - 1607. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Li, J. E. Lin, I. Chervoneva, S. Schulz, S. A. Waldman, and G. M. Pitari Homeostatic Control of the Crypt-Villus Axis by the Bacterial Enterotoxin Receptor Guanylyl Cyclase C Restricts the Proliferating Compartment in Intestine Am. J. Pathol., December 1, 2007; 171(6): 1847 - 1858. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Pitari, T. Li, R. I. Baksh, and S. A. Waldman Exisulind and guanylyl cyclase C induce distinct antineoplastic signaling mechanisms in human colon cancer cells Mol. Cancer Ther., May 1, 2006; 5(5): 1190 - 1196. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |